|
|
||||||||
Pharmazeutisches Institut der Frelen Universität Berlin, Berlin, FRG
Correspondence: For reprints contact: M. Wenzel, Pharmazeutisches Institut, 1000 Berlin 33, Koenigin-Luise-Str. 2-4, Germany.
ABSTRACT
Hydroxyacetyl [103Ru]ruthenocene and its o-glucuronide were prepared in vitro by incubation of acetyl [103Ru]ruthenocene with rat-liver homogenate, NADPH, and UDP-glucuronate. The factors affecting hydroxylation and glucuronidation in vitro were optimized for acetylruthenocene. Hydroxyacetyl [103Ru]ruthenocene glucuronide showed no affinity for the adrenal glands, but after i.v. administration of hydroxyacetyl [103Ru]ruthenocene there was a distinct accumulation of Ru-103 in adrenals, similar to that found after administration of acetyl [103Ru]ruthenocene.
This article has been cited by other articles:
![]() |
S. Charlap, B. Kimmel, J. Berezow, S. Molinas, J. Strom, J. Wexler, H. Willens, N. Klein, S. Pollack, and W. H. Frishman Lidoflazine and Propranolol Combination Treatment in Chronic Stable Angina Angiology, April 1, 1985; 36(4): 240 - 252. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |